Cargando…
Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy
The mannose phosphate isomerase-congenital disorder of glycosylation (MPI-CDG) is caused by phosphomannose isomerase deficiency. Clinical features include hyperinsulinaemic hypoglycaemia, protein losing enteropathy, hepatomegaly and hepatic fibrosis, digestive symptoms and coagulation abnormalities....
Autores principales: | Noman, Kinza, Hendriksz, Christian J., Radcliffe, Graham, Roncaroli, Federico, Moreea, Sulleman, Hussain, Afifah, Stepien, Karolina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490551/ https://www.ncbi.nlm.nih.gov/pubmed/32963965 http://dx.doi.org/10.1016/j.ymgmr.2020.100646 |
Ejemplares similares
-
Mannose treatment improves immune deficiency in mannose phosphate
isomerase–congenital disorder of glycosylation: case report and review of
literature
por: De Graef, Diederik, et al.
Publicado: (2022) -
Mannose phosphate isomerase gene mutation leads to a congenital disorder of glycosylation: A rare case report and literature review
por: Lu, Siliang, et al.
Publicado: (2023) -
ZIP10 is a negative determinant for anti-tumor effect of mannose in thyroid cancer by activating phosphate mannose isomerase
por: Ma, Sharui, et al.
Publicado: (2021) -
Footprints of natural selection at the mannose-6-phosphate isomerase locus in barnacles
por: Nunez, Joaquin C. B., et al.
Publicado: (2020) -
A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation
por: Chu, Jaime, et al.
Publicado: (2013)